PERRIGO Co Business Summary

Perrigo Company plc (PRGO) is a global leader in consumer self-care, primarily generating revenue through the development, manufacture, and distribution of over-the-counter (OTC) health and wellness products. As of Q1 2026, the company operates through three core reporting segments: Self Care (upper respiratory, digestive health, and pain/sleep aids), Specialty Care (women's health and skin health), and Infant Formula. Its business model is anchored in a dual-track strategy: dominating the North American market as the premier provider of private-label (store brand) equivalents for major retailers like Walmart and Amazon, while maintaining a robust portfolio of national brands in Europe, such as Compeed and Solpadeine. Perrigo competes directly with consumer health giants like Haleon, Kenvue, and Bayer AG, as well as generic manufacturers such as Dr. Reddy's Laboratories. It distinguishes itself as the world's largest manufacturer of OTC store-brand products, leveraging a vertically integrated supply chain to provide high-margin, value-oriented alternatives to national brands. Originally founded in 1887 by Luther Perrigo as a packager of home remedies, the company is currently led by President and CEO Patrick Lockwood-Taylor, who previously held senior leadership roles at Bayer Consumer Health and Procter & Gamble. The executive team includes CFO Eduardo Bezerra, formerly of Fresh Del Monte Produce, and Chief Scientific Officer Abbie Lennox. The leadership is currently executing the "Three-S" strategy (Simplify, Streamline, Strengthen) and "Project Energize" to optimize operational efficiency following the divestiture of its generic pharmaceutical and dermacosmetics businesses. Perrigo’s Board of Directors, chaired by Orlando D. Ashford, features notable industry veterans such as Jeffrey B. Kindler, the former Chairman and CEO of Pfizer, and Adriana Karaboutis, a former executive at Biogen and Dell. The company is publicly traded on the NYSE and maintains a significant institutional investor base, including major asset managers like Vanguard and BlackRock.